Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Theraphy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial
- 1 November 2007
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 155 (1) , 49-55
- https://doi.org/10.1016/j.ahj.2007.08.018
Abstract
No abstract availableKeywords
Funding Information
- Doris Duke Charitable Foundation
- Donald W. Reynolds Foundation
- Bristol-Myers Squibb
- Fondation Leducq
- National Institutes of Health (HL082740, HL57506, HL60942, U01 HL083-1341)
This publication has 22 references indexed in Scilit:
- Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular EventsCirculation, 2006
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesNew England Journal of Medicine, 2004
- Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary SyndromesCirculation, 2003
- Soluble CD40LCirculation, 2003
- Future of Biomarkers in Acute Coronary SyndromesCirculation, 2003
- S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunityMicroscopy Research and Technique, 2003
- Intracellular and extracellular roles of S100 proteinsMicroscopy Research and Technique, 2003
- Widespread Coronary Inflammation in Unstable AnginaNew England Journal of Medicine, 2002
- Inflammation and ThrombosisCirculation, 2001
- Myeloid related protein (MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of ApoE null miceAtherosclerosis, 2000